BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16797686)

  • 21. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.
    Hoekstra A; Singh DK; Garb M; Arekapudi S; Rademaker A; Lurain JR
    Gynecol Oncol; 2006 Dec; 103(3):897-901. PubMed ID: 16814370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
    Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
    Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of post-trachelectomy isthmic and vaginal smear cytology.
    Singh N; Titmuss E; Chin Aleong J; Sheaff MT; Curran G; Jacobs IJ; Shepherd JH
    Cytopathology; 2004 Apr; 15(2):97-103. PubMed ID: 15056170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine use of endometrial cytology in clinical practice.
    Bistoletti P; Hjerpe A
    Acta Cytol; 1993; 37(6):867-70. PubMed ID: 8249503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of routine follow-up of patients treated for endometrial carcinoma.
    Shumsky AG; Stuart GC; Brasher PM; Nation JG; Robertson DI; Sangkarat S
    Gynecol Oncol; 1994 Nov; 55(2):229-33. PubMed ID: 7959289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Abu-Rustum NR; Chi DS; Leitao M; Oke EA; Hensley ML; Alektiar KM; Barakat RR
    Gynecol Oncol; 2008 Oct; 111(1):46-8. PubMed ID: 18657853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
    Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF;
    Gynecol Oncol; 2007 Apr; 105(1):59-65. PubMed ID: 17150247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and utility of routine surveillance in high grade endometrial cancer.
    Hunn J; Tenney ME; Tergas AI; Bishop EA; Moore K; Watkin W; Kirschner C; Hurteau J; Rodriguez GC; Lengyel E; Lee NK; Yamada SD
    Gynecol Oncol; 2015 Jun; 137(3):485-9. PubMed ID: 25838164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
    Lamerato L; Havstad S; Gandhi S; Jones D; Nathanson D
    Cancer; 2006 May; 106(9):1875-82. PubMed ID: 16572409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent endometrial cancer: a retrospective study.
    van Wijk FH; Huikeshoven FJ; Abdulkadir L; Ewing PC; Burger CW
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):114-20. PubMed ID: 16460871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits.
    Coleridge S; Morrison J
    Int J Gynecol Cancer; 2020 Aug; 30(8):1177-1182. PubMed ID: 32376734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice patterns of SGO members for stage IIIA endometrial cancer.
    Lee CM; Slomovitz BM; Greer M; Sharma S; Gregurich MA; Burke T; Lu KH; Ramondetta LM
    Gynecol Oncol; 2005 Jul; 98(1):77-83. PubMed ID: 15907988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE; Huh WK; Fowler JM; Straughn JM
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which patients with colorectal cancer are followed up by general practitioners? A population-based study.
    Mahboubi A; Lejeune C; Coriat R; Binquet C; Bouvier AM; Béjean S; Bedenne L; Bonithon-Kopp C
    Eur J Cancer Prev; 2007 Dec; 16(6):535-41. PubMed ID: 18090126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.